By 2030, Vietnam would master production technologies of 30 types of vaccines and be capable of producing at least 20 types and all domestically developed vaccines would meet international standards and may compete in the international market.
By 2025, at least 15 types of vaccines would be produced domestically and the country would master production technologies of 25 types of vaccines.
Such targets are highlighted in the national program on research and production of vaccines for humans by 2030, drafted by Ministry of Science and Technology (the program).
 |
| Producing COVID-19 vaccines at Nanogen Pharmaceutical Biotechnology JSC. in Ho Chi Minh City__Photo: thiennhien.net |
The program, which would be submitted to the Prime Minister for approval, focuses on researching and applying advanced technologies to produce high-quality vaccines for humans, firstly for use under the Expanded Program on Immunization. It also aims at improving capacity of domestic vaccine researchers and producers in response to future epidemics and pandemics.
To this end, the draft proposes offering incentives to organizations and businesses engaged in research and transfer of vaccine production technologies like those for national products or hi-tech products.
Particularly, those that research or produce vaccines in response to a pandemic would receive financial support from the State to cover expenses for vaccine research, clinical trial, and trial production as well as for purchase of insurance and provision of remuneration for vaccine trial volunteers. The incentives introduced under the program would also apply to vaccines already approved under the National Product Development Program by 2020.
Funds for implementation of the program include funds from the state budget; funds of vaccine developers and producers; donations of domestic and foreign organizations and individuals; and other lawful sources.- (VLLF)
